| |
| |
Life Sciences Discussion Platform
Under the aegis of the Life Sciences High Level Group
European Commission - Research Directorate
Download
Programme brochure (PDF - 1.9Mb)
Download
Speakers and panellists abstracts (PDF - 2.24Mb)
|
| |
 |
| |
| Opening |
| 10:00 |
Adresses by
- European Commission
- P. Busquin, European Commissioner for Research
- European Union Presidency
- F.-X. De Donnea, Belgian Minister of Research
- European Parliament
– R. Goebbels, Chairman of the Temporary Committee
on Human Genetics and Other new Technologies of Modern
Medicine
|
| |
Chair:
A. Kahn |
 |
|
Setting
the scene:
the therapeutic, scientific and technological challenges |
|
|
| Focusing the problem:
the challenges of stem cells research |
|
| |
Chair:
H. Wigzell |
|
|
| 10:30 |
Video illustrating
basic concepts and potentials of stem cell based strategies. |
|
|
| 10:40 |
Opening lecture
P. Gruss, Max
Planck Institut, Göttingen |
|
|
| The input from
research: the available know-how and its potentials |
|
| |
Chair: C.
Nüsslein-Volhard |
| |
Opportunities
for and constrains on research, using different stem cell
systems: embryonic/foetal/adult stem cells, umbilical
cord blood. Each lecture is followed by a 10-minute discussion. |
|
|
| 11:10 |
Differentiation of human
embryonic stem cells
N. Benvenisty,
The Hebrew
University of Jerusalem |
|
|
| 11:50 |
The biology of adult
stem cells, M.Raff,
University College
London |
|
|
| 12:30–13:30 |
Parallel
session: Press Conference, Breydel Building |
|
|
| 12:30–14:00 |
Lunch
break, with transmission of press conference and video |
|
|
|
|
| |
| Therapeutic prospects:
the possible therapeutic outcomes |
|
| |
Chair: V.
De Lorenzo |
| |
Opportunities
and constrains within the clinical settings, including
safety issues: a selection of illustrative clinical cases.
Each lecture is followed by a 10-minute discussion. |
|
|
| 14:00 |
Prospects for a stem cell therapy for Parkinson's disease
A. Bjorklund,
Lund
University
|
|
|
| 14:30 |
New strategies in cell
therapy of diabetes mellitus
B. Soria, Universidad
Miguel Hernandez |
|
|
| 15:00 |
New sources of blood stem
cells: therapeutic implications, E.
Gluckman, Hôpital
Saint-Louis, Paris |
|
|
| Societal and ethical
key issues: the citizen’s rights |
|
| |
Chair: A.
McLaren |
| |
Views by/for
society. Each lecture is followed by a 10-minute discussion. |
|
|
| 15:30
|
The citizen's rights on information and dialogue
C. Tannert, Max-
Delbrueck- Center for Molecular Medicine, Berlin
|
|
|
| 16:00 |
Stem cells research and therapies - the ethical issues,
J. Harris,
University of Manchester
|
|
|
| 16:30 |
Using stem cells in research and development- a patients'
perspective on the ethical issue. A.
Kent, The
European Alliance of Patients and Parents Organisations
for Genetic Services and Innovation in Medicine.
|
|
|
| 17:00 |
An ethical/religious
view of stem cell research, E.
Schroten, University
of Utrecht, Center for Bioethics and Health Law |
|
|
| Round table 1 (focusing
on scientific, therapeutic and societal aspects) |
|
| |
Chair: D.
Burke |
| 17:30
–18:30 |
Round table
with a selected group representing all stakeholders: research
scientists, clinicians, industrialists, patients' groups,
ethicists, representatives from the public, and international
organisations. |
|
|
|
 |
| |
|
|
| |
| Nurturing
the debate |
| Round table 2 (focusing
on development and governance) |
|
| 14:30 |
Chair: D.
Burke |
| |
Round table
with a selected group representing all stakeholders: research
scientists, clinicians, industrials, patients’ groups,
ethicists, elected representatives and international organisations. |
|
|
| 15:30 |
Moderator:
J. Fritz-Vannahme |
| |
Exchange of
views and discussion, taken from different angles. |
|
|
| Conclusions |
|
|
| 17:00 |
A. Kahn, Life Sciences
High Level Group |
| |
|
|
| |
|
|
|
